The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis

Modern Rheumatology

Volumn 16, Issue 6, 2006, Pages 350-354

  Torikai, Eiji ^a   Kageyama, Yasunori ^a   Takahashi, Masaaki ^a   Nagano, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone metabolism marker; Methotrexate (MTX); Rheumatoid arthritis

Indexed keywords

ACTARIT; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CREACTIVE PROTEIN; DEOXYPYRIDINOLINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; BLOOD ANALYSIS; BONE METABOLISM; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG MECHANISM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JOINT SWELLING; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; URINALYSIS;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; AMINO ACIDS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BONE REMODELING; BONE RESORPTION; COLLAGEN TYPE I; FEMALE; HEALTH STATUS; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; OSTEOGENESIS; PEPTIDES; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 33845522875     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0517-z     Document Type: Article

References (34)

1. PN Sambrook 2002 The skeleton in rheumatoid arthritis; common mechanisms for bone erosion and osteoporosis? J Rheumatol 27 2541-2
2. I Joffe S Epstein 1991 Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management Semin Arthritis Rheum 20 256-72 2042057 10.1016/0049-0172(91)90021-Q 1:STN:280:By6B2M3osVw%3D
3. WP Arend JM Dayer 1995 Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis Arthritis Rheum 38 151-60 7848304 1:STN:280:ByqC2M7gsVY%3D
4. RN Maini PC Taylor 2000 Anti-cytokine therapy for rheumatoid arthritis Annu Rev Med 51 207-29 10774461 10.1146/annurev.med.51.1.207 1:CAS:528:DC%2BD3cXisVelsbg%3D
5. AB Cranney RJ McKendry GA Wells DS Ooi ND Kanifsberg GR Kraag 2001 The effect of low dose methotrexate on bone density J Rheumatol 28 2395-9 11708409 1:CAS:528:DC%2BD3MXpt1Whsbk%3D
6. El Miedany HL Iman EL Mohamed 1998 Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis J Rheumatol 25 2083-7 9818648
7. P Garnero PD Delmas 1996 New developments in biochemical markers for osteoporosis Calcif Tissue Int 59 Suppl 1 82-9
8. FC Arnett SM Edworthy DA Bloch DJ McShane NS Fries LA Healey 1988 The American Rheumatism Association's 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315-24 3358796 1:STN:280:BieC1M3nt1Q%3D
9. T Pincus JA Summary SA Soraci Jr KA Wallston NP Hummon 1983 Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire Arthritis Rheum 26 1346-53 6639693 1:STN:280:BiuD2M3mt1Q%3D
10. DT Felson JJ Anderson M Boers C Bombardier D Furst C Goldsmith 1995 American Collage of Rheumatology preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 6 727-35
11. AK Gough NF Peel R Eastell RL Holder J Lilley P Emery 1994 excretion of PyridInium CrosslInks correlates with disease activity and appendicular bone loss In early rheumatoid arthritis Ann Rheum Dis 53 14-7 8311548 1:STN:280:ByuC2crhsl0%3D
12. G Kollerup M Hansen PK Horslev 1994 Urinary hydroxyproline crosslinks of collagen in rheumatoid arthritis Br J Rheumatol 33 816-20 8081665 1:STN:280:ByuA28zhsVQ%3D
13. RM Pereira J Corrente W Chahade W Cossermelli 1996 Levels of deoxypyridinoline cross-links in healthy children and children with juvenile rheumatoid arthritis (abstract) Arthritis Rheum 7 902-6
14. WP Arend JM Dayer 1995 Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis Arthritis Rheum 38 151-60 7848304 1:STN:280:ByqC2M7gsVY%3D
15. RN Maini PC Taylor 2000 Anti-cytokine therapy for rheumatoid arthritis Annu Rev Med 51 207-29 10774461 10.1146/annurev.med.51.1.207 1:CAS:528:DC%2BD3cXisVelsbg%3D
16. Y Azuma K Kaji R Katori S Takeshita A Kudo 2000 Tumor necrosis factor - alpha induces differentiation of and bone resorption by osteoclasts J Biol Chem 275 4858-64 10671521 10.1074/jbc.275.7.4858 1:CAS:528:DC%2BD3cXhsVyms74%3D
17. YH Zhang A Heulsmann MM Tondravi A Mukherjee Y Abu-Amer 2001 Tumor necrosis factor-alpha (TNF) stimulates RANK signaling pathways J Biol Chem 276 563-8 11032840 10.1074/jbc.M008198200 1:CAS:528:DC%2BD3MXmtFSquw%3D%3D
18. K Kobayashi K Takahashi E Jimi 2000 Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J Exp Med 191 275-86 10637272 10.1084/ jem.191.2.275 1:CAS:528:DC%2BD3cXntFenug%3D%3D
19. E Jijmi S Akiyama T Tsurukai 1999 Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function J Immunol 163 434-42
20. K Fuller B Wong S Fox 1998 TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts J Exp Med 188 997-1001 9730902 10.1084/jem.188.5.997 1:CAS:528:DyaK1cXmtVagtb8%3D
21. IR Reid 1997 Gulcocortocoid osteoporosis-mechanisms and management Eur J Endocrinol 137 209-17 9330580 10.1530/eje.0.1370209 1:CAS:528:DyaK2sXntVyksrk%3D
22. BP Lukert LG Raisz 1990 Glucocortocoid-induced osteoporosis: pathogenesis and management Ann Intern Med 112 352-64 2407167 1:CAS:528:DyaK3cXktlCktrs%3D
23. CH Kim SL Cheng GS Kim 1999 Effect of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: Possible mechanisms of glucocorticoid-induced bone loss J Endocrinol 162 371-9 10467228 10.1677/joe.0.1620371 1:CAS:528:DyaK1MXmtFCiurY%3D
24. D Dempster 1998 Bone histomorphometry in glucocorticoid-induced osteoporosis J Bone Miner Res 13 137-41
25. T Fujita A Satomura M Hidaka I Ohsawa M Endo H Ohi 2000 Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephritic patients receiving high-dose glucocorticoid and one cycle etidronate therapy Calcif Tissue Int 66 195-9 10666494 10.1007/ s002230010039 1:CAS:528:DC%2BD3cXhslSiur0%3D
26. RS Weinstein RL Jilka AM Parfit SC Manolagas 1998 Inhibition of osteoclastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone J Clin Invest 102 274-82 9664068 1:CAS:528:DyaK1cXkslOktrc%3D
27. C Gennari B Imbimbo M Montagnani M Bermini P Nardi LV Avioli 1984 Effect of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans Calcif Tissue Int 36 245-52 6432287 10.1007/ BF02405325 1:STN:280:BiuB1c3gs1Q%3D
28. DW Dempster 1994 Bone histomorphometry in glucocorticoid-induced osteoporosis J Bone Miner Res 56 295-302
29. WF Lems MI Gerrits JWG Jacobs RM van Vugt HJM van Rijn JWJ Bijlsma 1996 Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis Ann Rheum Dis 55 288-93 8660101 1:CAS:528:DyaK28Xjslentbg%3D
30. K Yonemura M Kimura T Miyaji A Hishida 2000 Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis Calcif Tissue Int 66 123-8 10652960 10.1007/PL00005832 1:CAS:528:DC%2BD3cXpslKhtg%3D%3D
31. S Greenspan H Rosen R Parker 1998 Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: A randomized clinical trial J Bone Miner Res 13 1431-8 9738515 10.1359/jbmr.1998.13.9.1431 1:CAS:528:DyaK1cXmtVCjsrg%3D
32. P Ravn B Clemmesen C Christiansen 1999 Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women Bone 24 237-44 10071916 10.1016/ S8756-3282(98)00183-5 1:CAS:528:DyaK1MXhslCrurg%3D
33. EW St Clair SA Moak WE Wilkinson L Sanders T Lang RA Greenwald 1998 A cross sectional analysis of 5 different markers f collagen degradation in rheumatoid arthritis J Rheumatol 25 1472-9 9712086 1:CAS:528:DyaK1cXlsF2is7g%3D
34. GM Hall TD Spector PD Delmas 1995 markers of bone metabolism In postmenopausal women with rheumatoid arthritis: Effects of corticosteroids and hormone replacement therapy Arthritis Rheum 38 902-6 7612039 1:STN:280:ByqA3snkvVc%3D